Portfolio company Enanta enters into strategic collaboration with Novartis
(Thomson Reuters ONE) -
Private Equity Holding AG /
Portfolio company Enanta enters into strategic collaboration with Novartis
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Ad hoc Press Release
Zug, February 21, 2012
Portfolio company Enanta enters into strategic collaboration with Novartis
Private Equity Holding AG (PEH) is pleased to inform that portfolio company
Enanta Pharmaceuticals (Enanta) has entered into a strategic collaboration with
Novartis for the worldwide development, manufacture and commercialization of its
lead development candidate, EDP-239, from its NS5A hepatitis C virus (HCV)
inhibitor program. PEH is a minority shareholder (<10%) and invested in Enanta
in 1999 as part of the original shareholder syndicate.
For more information on the strategic collaboration with Novartis and Enanta,
please refer tohttp://www.enanta.com/pr_022112.html or http://www.enanta.com.
***
Private Equity Holding AG (SIX: PEHN), managed by Alpha Associates, offers
investors the opportunity to invest, within a simple legal and tax optimized
structure, in a broadly diversified and professionally managed private equity
portfolio.
For further information, please contact:
Peter Wolfers, Investor Relations,peter.wolfers(at)peh.ch, phone +41 41 726 79 80
or http://www.peh.ch.
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Private Equity Holding AG via Thomson Reuters ONE
[HUG#1588012]
Unternehmensinformation / Kurzprofil:
Datum: 21.02.2012 - 18:50 Uhr
Sprache: Deutsch
News-ID 116942
Anzahl Zeichen: 2129
contact information:
Town:
Zug
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 196 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Portfolio company Enanta enters into strategic collaboration with Novartis"
steht unter der journalistisch-redaktionellen Verantwortung von
Private Equity Holding AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
